Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Xu

Showing results (601-610 of 808) with videos related to

Pageof 81
Sort By:
Science Translational Medicine|June 14, 2019
A systems genomics approach identifies <i>SIGLEC15</i> as a susceptibility factor in recurrent vulvovaginal candidiasisM Jaeger, M Pinelli, M Borghi, et al.
Nature Communications|January 24, 2025
Stable laser-acceleration of high-flux proton beams with plasma collimationM J V Streeter, G D Glenn, S DiIorio, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms]M Y Zhang, M Bao, D Y Shi, et al.
Journal of Biomedical Optics|November 13, 2025
Consensus guidelines for cellular label-free optical metabolic imaging: ensuring accuracy and reproducibility in metabolic profilingIrene Georgakoudi, Melissa C Skala, Kyle P Quinn, et al.
Cell|March 7, 2026
β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancerShan Liu, Puneeth Guruprasad, Ranjani Ramasubramanian, et al.
Physical Review Letters|September 5, 2001
Two-kaon correlations in central Pb+Pb collisions at 158 a GeV/cI G Bearden, H Bøggild, J Boissevain, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 8, 2024
[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study]X S Zhang, B C Liu, X Du, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2023
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia]X S Zhang, B C Liu, X Du, et al.
Physical Review Letters|April 6, 2001
Event-by-event fluctuations of the Kaon-to-Pion ratio in central Pb+Pb collisions at 158 GeV per nucleonS V Afanasiev, T Anticic, J Bächler, et al.
Physical Review Letters|January 22, 2002
Measurement of inclusive antiprotons from Au+Au collisions at square root of s(NN) = 130 GeVC Adler, Z Ahammed, C Allgower, et al.
Pageof 81

Showing results (601-610 of 808) with videos related to

Sort By:
Pageof 81
Science Translational Medicine|June 14, 2019
A systems genomics approach identifies <i>SIGLEC15</i> as a susceptibility factor in recurrent vulvovaginal candidiasisM Jaeger, M Pinelli, M Borghi, et al.
Nature Communications|January 24, 2025
Stable laser-acceleration of high-flux proton beams with plasma collimationM J V Streeter, G D Glenn, S DiIorio, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms]M Y Zhang, M Bao, D Y Shi, et al.
Journal of Biomedical Optics|November 13, 2025
Consensus guidelines for cellular label-free optical metabolic imaging: ensuring accuracy and reproducibility in metabolic profilingIrene Georgakoudi, Melissa C Skala, Kyle P Quinn, et al.
Cell|March 7, 2026
β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancerShan Liu, Puneeth Guruprasad, Ranjani Ramasubramanian, et al.
Physical Review Letters|September 5, 2001
Two-kaon correlations in central Pb+Pb collisions at 158 a GeV/cI G Bearden, H Bøggild, J Boissevain, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 8, 2024
[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study]X S Zhang, B C Liu, X Du, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2023
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia]X S Zhang, B C Liu, X Du, et al.
Physical Review Letters|April 6, 2001
Event-by-event fluctuations of the Kaon-to-Pion ratio in central Pb+Pb collisions at 158 GeV per nucleonS V Afanasiev, T Anticic, J Bächler, et al.
Physical Review Letters|January 22, 2002
Measurement of inclusive antiprotons from Au+Au collisions at square root of s(NN) = 130 GeVC Adler, Z Ahammed, C Allgower, et al.
Pageof 81